The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA
Journal of Cell Biology · 2023
DOI: 10.1083/jcb.202201027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Biology, 2023. Verfasst von Ellis G Jaffray und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee , Dundee, UK. Hauptthemen laut MEDLINE: Arsenic, Leukemia, Promyelocytic, Acute, Valosin Containing Protein. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Wellcome Trust, European Union’s Horizon 2020.
Abstract (Originalsprache)
Acute Promyelocytic Leukemia is caused by expression of the oncogenic Promyelocytic Leukemia (PML)–Retinoic Acid Receptor Alpha (RARA) fusion protein. Therapy with arsenic trioxide results in degradation of PML-RARA and PML and cures the disease. Modification of PML and PML-RARA with SUMO and ubiquitin precedes ubiquitin-mediated proteolysis. To identify additional components of this pathway, we performed proteomics on PML bodies. This revealed that association of p97/VCP segregase with PML bodies is increased after arsenic treatment. Pharmacological inhibition of p97 altered the number, morphology, and size of PML bodies, accumulated SUMO and ubiquitin modified PML and blocked arsenic-induced degradation of PML-RARA and PML. p97 localized to PML bodies in response to arsenic, and siRNA-mediated depletion showed that p97 cofactors UFD1 and NPLOC4 were critical for PML degradation. Thus, the UFD1-NPLOC4-p97 segregase complex is required to extract poly-ubiquitinated, poly-SUMOylated PML from PML bodies, prior to degradation by the proteasome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee , Dundee, UK.
ORCID-Profile: Ellis G Jaffray, Michael H Tatham, Barbara Mojsa, Magda Liczmanska, Alejandro Rojas-Fernandez, Yili Yin, Graeme Ball, Ronald T Hay
Förderung
- Cancer Research UK
- Wellcome Trust
- European Union’s Horizon 2020
Zitieren
APA
Jaffray, E. G., Tatham, M. H., Mojsa, B., Liczmanska, M., Rojas-Fernandez, A., Yin, Y., Ball, G., & Hay, R. T. (2023). The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. Journal of Cell Biology. https://doi.org/10.1083/jcb.202201027
Vancouver
Jaffray EG, Tatham MH, Mojsa B, Liczmanska M, Rojas-Fernandez A, Yin Y, et al. The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. Journal of Cell Biology. 2023. doi:10.1083/jcb.202201027
BibTeX
@article{Jaffray2023,
author = {Jaffray, Ellis G and Tatham, Michael H and Mojsa, Barbara and Liczmanska, Magda and Rojas-Fernandez, Alejandro and Yin, Yili and Ball, Graeme and Hay, Ronald T},
title = {The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA},
journal = {Journal of Cell Biology},
year = {2023},
doi = {10.1083/jcb.202201027}
}
EUVIMED